Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,224 | -67,251 | -92,141 | -81,836 | -188,863 |
| Depreciation Amortization | 100,150 | 75,465 | 50,920 | 26,339 | 106,519 |
| Income taxes - deferred | 14,744 | 7,695 | -4,477 | -2,680 | 146 |
| Accounts receivable | -220 | 15,680 | 15,353 | 9,518 | 3,411 |
| Accounts payable and accrued liabilities | -20,662 | -6,527 | 13,688 | 2,789 | 2,828 |
| Other Working Capital | 32,175 | 49,151 | 28,917 | 14,214 | 21,799 |
| Other Operating Activity | -256,452 | -213,293 | -74,261 | -3,910 | 25,963 |
| Operating Cash Flow | $-183,489 | $-139,080 | $-62,001 | $-35,566 | $-28,197 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -1,454 | N/A | N/A | N/A |
| PPE Investments | -24,768 | -19,428 | -11,557 | -4,395 | -13,562 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -5,000 |
| Sale Of Investment | 166,604 | 46,731 | N/A | N/A | 364 |
| Other Investing Activity | 210,378 | 210,378 | 0 | 0 | 0 |
| Investing Cash Flow | $352,214 | $236,227 | $-11,557 | $-4,395 | $-18,198 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 459,432 | 448,459 | 317,811 | 163,703 | 671,678 |
| Debt Issued | 480,000 | 480,000 | 230,000 | 230,000 | N/A |
| Debt Repayment | -176,389 | -151,168 | -146,287 | -146,287 | -3,000 |
| Common Stock Issued | -208 | -208 | -208 | N/A | -272 |
| Common Stock Repurchased | -90,223 | -73,759 | -50,000 | -50,000 | N/A |
| Other Financing Activity | -488,446 | -478,686 | -332,818 | -176,803 | -679,709 |
| Financing Cash Flow | $184,166 | $224,638 | $18,498 | $20,613 | $-11,303 |
| Exchange Rate Effect | -3,157 | 2,399 | -245 | -894 | 388 |
| Beginning Cash Position | 95,881 | 95,881 | 95,881 | 95,881 | 153,191 |
| End Cash Position | 445,615 | 420,065 | 40,576 | 75,639 | 95,881 |
| Net Cash Flow | $349,734 | $324,184 | $-55,305 | $-20,242 | $-57,310 |
| Free Cash Flow | |||||
| Operating Cash Flow | -183,489 | -139,080 | -62,001 | -35,566 | -28,197 |
| Capital Expenditure | -25,010 | -19,597 | -11,660 | -4,443 | -16,275 |
| Free Cash Flow | -208,499 | -158,677 | -73,661 | -40,009 | -44,472 |